Your browser of choice has not been tested for use with Barchart.com. If you have issues, please download one of the browsers listed here.
Screeners that run automatically... and then email you the results! FREE 30 Day Trial

Stocks | Futures | Watchlist | More
or

Journey Medical Corp (DERM)

Journey Medical Corp (DERM)

[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
News & Headlines for [[ item.sessionDateDisplayLong ]]
Journey Medical Corporation (DERM) Reports Q3 Loss, Misses Revenue Estimates

Journey Medical Corporation (DERM) delivered earnings and revenue surprises of -67.65% and 11.59%, respectively, for the quarter ended September 2022. Do the numbers hold clues to what lies ahead for the...

DERM : 1.7400 (+2.35%)
XBIO : 0.4720 (-3.42%)
Journey Medical Corporation (DERM) Reports Q2 Loss, Lags Revenue Estimates

Journey Medical Corporation (DERM) delivered earnings and revenue surprises of -72% and 13.97%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

DERM : 1.7400 (+2.35%)
KMPH : 4.76 (+1.06%)
Journey Medical Corporation Reports Second Quarter 2022 Financial Results and Recent Corporate Highlights

Second quarter 2022 net revenue increased 20% to $18.3 million versus the same quarter of 2021 DFD-29 Phase 3 studies 45% enrolled to date; 9 additional...

DERM : 1.7400 (+2.35%)
FBIO : 0.7250 (-1.37%)
Sigilon Therapeutics, Inc. (SGTX) Reports Q2 Loss, Tops Revenue Estimates

Sigilon Therapeutics, Inc. (SGTX) delivered earnings and revenue surprises of 4.35% and 22.68%, respectively, for the quarter ended June 2022. Do the numbers hold clues to what lies ahead for the stock?...

SGTX : 0.4580 (+7.76%)
DERM : 1.7400 (+2.35%)
Molecular Templates Inc. (MTEM) Expected to Beat Earnings Estimates: Can the Stock Move Higher?

Molecular Templates Inc. (MTEM) possesses the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.

MTEM : 0.5906 (-2.70%)
DERM : 1.7400 (+2.35%)
Journey Medical Corporation Announces Settlement Agreements Pertaining to QBREXZA®, AMZEEQ® and ZILXI® Patent Exclusivity

SCOTTSDALE, Ariz., May 24, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (NASDAQ: DERM) (“Journey Medical” or the “Company”), a commercial-stage...

FBIO : 0.7250 (-1.37%)
DERM : 1.7400 (+2.35%)
Journey Medical Corporation to Present at the B. Riley Securities 22nd Annual Institutional Investor Conference

SCOTTSDALE, Ariz., May 23, 2022 (GLOBE NEWSWIRE) -- Journey Medical Corporation (“Journey Medical”) (NADSAQ: DERM), a commercial-stage pharmaceutical...

FBIO : 0.7250 (-1.37%)
DERM : 1.7400 (+2.35%)
36 of the Best Ideas Companies to Present at the Spring into Action - Best Ideas Investor Conference on May 16th - 20th, 2022

RALEIGH, NC / ACCESSWIRE / May 16, 2022 / The Spring into Action- Best Ideas Virtual Investor Conference will take place on May 16th - 20th, 2022, where 36 SmallCap, MicroCap and NanoCap public companies...

ACST : 0.4199 (+1.38%)
LPTH : 1.2900 (+7.50%)
RCAT : 1.1850 (+1.28%)
IONM : 0.4499 (+4.63%)
PYR : 0.8494 (+3.53%)
OSS : 3.10 (unch)
MODD : 3.58 (+7.90%)
STRN : 1.4050 (-1.75%)
AEYE : 4.78 (-2.88%)
SMFL : 0.4150 (+5.84%)
LFMD : 2.64 (+1.54%)
SURG : 6.32 (+4.46%)
Journey Medical Corporation Reports First Quarter 2022 Financial Results and Recent Corporate Highlights

Generated record revenue of $23.3 million for the first quarter of 2022 First patient dosed in Phase 3 clinical program evaluating DFD-29 for the...

DERM : 1.7400 (+2.35%)
FBIO : 0.7250 (-1.37%)
Journey Medical Corporation to Announce First Quarter 2022 Financial Results on May 10, 2022

Company to host conference call to discuss financial results and provide a corporate update on May 10, 2022 at 4:30 p.m. ET...

FBIO : 0.7250 (-1.37%)
DERM : 1.7400 (+2.35%)

Barchart Exclusives

Strong Seasonality And Other Key Themes To Watch This Week
It was a slow week last week in the markets with a short week in the US. There were still plenty of potential trades early in the week, but as Thanksgiving approached volume slowed down and the markets became whippy with no stabilizing forces. Read more

Barchart Futures Commentary

Barchart Futures is a twice weekly newsletter that features a selection of the latest and best commodities commentary appearing on Barchart.com. Delivered every Wednesday and Friday morning to your inbox.

Want to use this as
your default charts setting?
Save this setup as a Chart Templates
Switch the Market flag
for targeted data from your country of choice.
Open the menu and switch the
Market flag for targeted data from your country of choice.
Want Streaming Chart Updates?
Switch your Site Preferences
to use Interactive Charts
Need More Chart Options?
Right-click on the chart to open the Interactive Chart menu.

Free Barchart Webinar